Could a gut pill boost brain health in dementia?
NCT ID NCT06718686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new version of a gut antibiotic called rifaximin in 20 people with mild-to-moderate Alzheimer's or vascular dementia. The goal is to see if changing the bacteria in the gut can improve brain function and reduce inflammation. Participants will take the drug or a placebo in two phases, and researchers will measure changes in blood and stool markers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA ALZHEIMER TYPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Richmond VA Medical Center
RECRUITINGRichmond, Virginia, 23249, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple memory test could spot dementia in Low-Education groups
- New program focuses on strengths, not deficits, to help dementia patients and caregivers
- Can a simple quiz predict brain health in aging? italian study aims to find out
- Zapping the brain to calm dementia agitation
- Can your phone predict memory decline? new study tracks stress and thinking in seniors
- Can a computer program boost brain health in seniors with memory loss?